Early Adoption of Tenofovir Alafenamide (TAF) for Hepatitis B in US Clinical Practice; Real-World Evidence from the Trio Network Curry, M. P., Bae, H., Dieterich, D. T., Ankoma-Sey, V., Reddy, K., Pan, C. Q., Hann, H. L., Tong, M. J., Kim, W., Kwo, P., Reau, N., Frazier, L., Milligan, S., Afdhal, N. H. WILEY. 2018: 252A

View details for Web of Science ID 000446020500426